{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:47:00Z","timestamp":1793774820931,"version":"4.6.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"French Vasculitis Study Group"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic small-vessel vasculitis characterized by asthma, hypereosinophilia and ANCA positivity in 40% of patients. Renal involvement is rare and poorly described, leading to this renal biopsy-proven based study in a large EGPA cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective multicentre study including patients fulfilling the 1990 ACR criteria and\/or the 2012 revised Chapel Hill Consensus Conference criteria for EGPA and\/or the modified criteria of the MIRRA trial, with biopsy-proven nephropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Sixty-three patients [27 women, median age 60\u2009years (18\u201383)] were included. Renal disease was present at vasculitis diagnosis in 54 patients (86%). ANCA were positive in 53 cases (84%) with anti-MPO specificity in 44 (83%). All patients had late-onset asthma. Peripheral neuropathy was present in 29 cases (46%), alveolar haemorrhage in 10 (16%). The most common renal presentation was acute renal failure (75%). Renal biopsy revealed pauci-immune necrotizing GN in 49 cases (78%). Membranous nephropathy (10%) and membranoproliferative GN (3%) were mostly observed in ANCA-negative patients. Pure acute interstitial nephritis was found in six cases (10%); important interstitial inflammation was observed in 28 (44%). All patients received steroids with adjunctive immunosuppression in 54 cases (86%). After a median follow-up of 51\u2009months (1\u2013296), 58 patients (92%) were alive, nine (14%) were on chronic dialysis and two (3%) had undergone kidney transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Necrotizing pauci-immune GN is the most common renal presentation in ANCA-positive EGPA. ANCA-negative patients had frequent atypical renal presentation with other glomerulopathies such as membranous nephropathy. An important eosinophilic interstitial infiltration was observed in almost 50% of cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa416","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T15:10:49Z","timestamp":1593616249000},"page":"359-365","source":"Crossref","is-referenced-by-count":50,"title":["Renal involvement in eosinophilic granulomatosis with polyangiitis (EGPA): a multicentric retrospective study of 63 biopsy-proven cases"],"prefix":"10.1093","volume":"60","author":[{"given":"C\u00e9cile-Audrey","family":"Durel","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Edouard Herriot, Hospices Civils De Lyon, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato A","family":"Sinico","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, Universita di Milano-Biococca, Milano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor","family":"Teixeira","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Centro Hospitalar Universit\u00e1rio do Algarve, Faro, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Jayne","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Belenfant","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Centre Hospitalier Intercommunal Andr\u00e9 Gr\u00e9goire, Montreuil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Marchand-Adam","sequence":"additional","affiliation":[{"name":"Department of Pneumology, H\u00f4pital Bretonneau, Tours"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Pugnet","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Purpan, Toulouse"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Gaultier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CH Gap, Gap"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Le Gallou","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHRI Rennes Site H\u00f4pital Sud, Rennes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Titeca-Beauport","sequence":"additional","affiliation":[{"name":"Department of Nephrology, CHU Amiens-Picardie, Amiens"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Agard","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHU de Nantes Site H\u00f4tel Dieu-HME, Nantes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Barbet","sequence":"additional","affiliation":[{"name":"Department of Nephrology, CHRU Bretonnneau-Tours, Tours"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bardy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Centre Hospitalier Moulins-Yzeure, Moulins, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blockmans","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, KU Leuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Boffa","sequence":"additional","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Tenon AP-HP, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bouet","sequence":"additional","affiliation":[{"name":"Department of Nephrology, CHPC Site Cherbourg, Cherbourg Octeville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5591-0955","authenticated-orcid":false,"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[{"name":"National Coordinating Reference Centre for Rare Pulmonary Diseases, H\u00f4pital Louis Pradel, Hospices Civils De Lyon, University Claude Bernard Lyon 1, Lyon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Crabol","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHBA Site de Vannes, Vannes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Deligny","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Internal Medicine, CHU Martinique, H\u00f4pital P. Zobda-Quitman, Fort-de-France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Essig","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hopital Ambroise Par\u00e9, Boulogne-Billancourt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Godmer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHBA Site de Vannes, Vannes"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Guilpain","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2014Multi-Organ Diseases, Montpellier University-Saint Eloi Hospital, Montpellier"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Hirschi-Santelmo","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Nouvel H\u00f4pital Civil, HUS, Strasbourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Rafat","sequence":"additional","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Tenon AP-HP, Paris"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Pu\u00e9chal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, H\u00f4pital Cochin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Taill\u00e9","sequence":"additional","affiliation":[{"name":"Department of Respiratory Diseases, H\u00f4pital Bichat"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Karras","sequence":"additional","affiliation":[{"name":"Department of Nephrology, H\u00f4pital Europ\u00e9en Georges Pompidou, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the French Vasculitis Study Group (FVSG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"2021010517021324400_keaa416-B1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0031-1279826","article-title":"Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment","volume":"32","author":"Dunogu\u00e9","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"2021010517021324400_keaa416-B2","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"key":"2021010517021324400_keaa416-B3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2012.08.006","article-title":"Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis","volume":"12","author":"Sinico","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2021010517021324400_keaa416-B4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/ndt\/5.3.161","article-title":"Renal involvement in Churg-Strauss syndrome","volume":"5","author":"Clutterbuck","year":"1990","journal-title":"Nephrol Dial Transplant"},{"key":"2021010517021324400_keaa416-B5","doi-asserted-by":"crossref","first-page":"101.","DOI":"10.1186\/s12882-016-0319-2","article-title":"Long-term outcomes in antineutrophil cytoplasmic autoantibody-positive eosinophilic granulomatosis with polyangiitis patients with renal involvement: a retrospective study of 14 Chinese patients","volume":"17","author":"Chen","year":"2016","journal-title":"BMC Nephrol"},{"key":"2021010517021324400_keaa416-B6","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2006.01.026","article-title":"Renal involvement in Churg-Strauss syndrome","volume":"47","author":"Sinico","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2021010517021324400_keaa416-B7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.autrev.2014.12.004","article-title":"Churg-Strauss syndrome","volume":"14","author":"Greco","year":"2015","journal-title":"Autoimmun Rev"},{"key":"2021010517021324400_keaa416-B8","doi-asserted-by":"crossref","first-page":"102495.","DOI":"10.1016\/j.autrev.2020.102495","article-title":"Clinical associations of renal involvement in ANCA-associated vasculitis","volume":"19","author":"Kronbichler","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2021010517021324400_keaa416-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2021010517021324400_keaa416-B10","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.1780330812","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary","volume":"33","author":"Fries","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021010517021324400_keaa416-B11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2021010517021324400_keaa416-B12","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"2021010517021324400_keaa416-B13","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1136\/ard.2008.101279","article-title":"Modification and validation of the Birmingham Vasculitis Activity Score (version 3)","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"2021010517021324400_keaa416-B14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2021010517021324400_keaa416-B15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2215\/CJN.06150613","article-title":"Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease","volume":"9","author":"Chu","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021010517021324400_keaa416-B16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","article-title":"KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD","volume":"63","author":"Inker","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"2021010517021324400_keaa416-B17","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/ki.2009.53","article-title":"Chronic kidney disease definition and classification: no need for a rush to judgment","volume":"75","author":"Eknoyan","year":"2009","journal-title":"Kidney Int"},{"key":"2021010517021324400_keaa416-B18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.2006.062711","article-title":"EULAR recommendations for conducting clinical studies and\/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis","volume":"66","author":"Hellmich","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2021010517021324400_keaa416-B19","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","article-title":"Histopathologic classification of ANCA-associated glomerulonephritis","volume":"21","author":"Berden","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"2021010517021324400_keaa416-B20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.kint.2018.07.020","article-title":"Development and validation of a renal risk score in ANCA-associated glomerulonephritis","volume":"94","author":"Brix","year":"2018","journal-title":"Kidney Int"},{"key":"2021010517021324400_keaa416-B21","article-title":"All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type","author":"Wallace","journal-title":"Rheumatology"},{"key":"2021010517021324400_keaa416-B22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.autrev.2012.08.008","article-title":"Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis","volume":"12","author":"Radice","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2021010517021324400_keaa416-B23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sabl\u00e9-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"2021010517021324400_keaa416-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2016.09.018","article-title":"Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d\u2019Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss","volume":"16","author":"Cottin","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2021010517021324400_keaa416-B25","first-page":"320","article-title":"Membranous glomerulopathy associated with idiopathic hypereosinophilic syndrome","volume":"21","author":"Frigui","year":"2010","journal-title":"Saudi J Kidney Dis Transplant"},{"key":"2021010517021324400_keaa416-B26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1681\/ASN.2011040330","article-title":"Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy","volume":"23","author":"Berden","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2021010517021324400_keaa416-B27","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ndt\/gfu084","article-title":"ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis","volume":"29","author":"Quintana","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2021010517021324400_keaa416-B28","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2169\/internalmedicine.44.853","article-title":"Membranous glomerulopathy induced by myeloperoxidase-anti-neutrophil cytoplasmic antibody-related crescentic glomerulonephritis","volume":"44","author":"Suwabe","year":"2005","journal-title":"Intern Med"},{"key":"2021010517021324400_keaa416-B29","doi-asserted-by":"crossref","first-page":"e1472.","DOI":"10.1097\/MD.0000000000001472","article-title":"Clinical and immunologic characteristics of patients with ANCA-associated glomerulonephritis combined with membranous nephropathy: a retrospective cohort study in a single Chinese center","volume":"94","author":"Zou","year":"2015","journal-title":"Medicine"},{"key":"2021010517021324400_keaa416-B30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2021010517021324400_keaa416-B31","doi-asserted-by":"crossref","first-page":"e4633.","DOI":"10.1097\/MD.0000000000004633","article-title":"Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature","volume":"95","author":"Della-Torre","year":"2016","journal-title":"Medicine"},{"key":"2021010517021324400_keaa416-B32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1681\/ASN.2018080852","article-title":"Exostosin 1\/exostosin 2-associated membranous nephropathy","volume":"30","author":"Sethi","year":"2019","journal-title":"J Am Soc Nephrol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/1\/359\/35433527\/keaa416.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/1\/359\/35433527\/keaa416.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T03:54:04Z","timestamp":1610250844000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/1\/359\/5898459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,8,28]]},"published-print":{"date-parts":[[2021,1,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa416","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,1]]},"published":{"date-parts":[[2020,8,28]]}}}